BNY Underweight: Trim 35-45% with $150.50 stop; exit prior to Q3 2026 earnings
Underweight wins decisively on directional merits—technical break is decisive with 3.3% violation of 50 SMA at $159.16, fresh MACD bearish cross on September 15 (histogram at -1.29), 10 EMA rolled beneath 50 SMA in textbook bearish order, and Q2 2026 EPS stalled sequentially at $2.45 after six consecutive quarters of acceleration. However, the empirical ceiling cap binds sizing: 2026-09-14 Underweight produced only -1.4% alpha and 2026-09-11 produced only -2.6% alpha, confirming -1.5% to -2.5% structural cap for BNY Underweight. Full Sell is ruled out given intact structural floor (200 SMA at $134.58 with 14% buffer, 14.1% ROE, 40% operating margin, $62T AUC custody fortress, $4.5B annual buybacks, improving AOCI from -$4.66B to -$3.50B). Pure Hold is also not defensible given three recent Holds producing -0.3%, +0.6%, and -1.5% alpha, explicitly invalidating the historical +0.4% to +2.6% Hold base rate in trending-regime conditions. The 35-45% trim is the calibrated middle that captures meaningful risk reduction without overcommitting; the bilateral tripwires at $156.66 (up) and $134 (down) generate measurable outcomes rather than ambiguous alpha prints.
| Position | Action |
|---|---|
| Current portfolio weight to reduce | Trim 35-45% to achieve Underweight stance |
BNY's current pullback to $153.89 represents a gift, not a warning, as the stock remains 14.4% above a rising 200 SMA with contracting volatility signatures and mean-reversion setup at the lower Bollinger Band, while fundamentals accelerate at 27% YoY EPS growth and 29.5% net income CAGR, making the PEG ratio of 1.16 on 20% forward EPS growth reasonable for an elite compounder with 40% operating margins.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 134.58 | bullish |
| close_50_sma | 159.16 | bearish |
| close_10_ema | 156.66 | bearish |
| rsi | 36.51 | bearish |
| macd | -1.38 | bearish |
| macdh | -1.29 | bearish |
| boll_lb | 152.04 | bullish |
| atr | 3.07 | neutral |
Support: 152.04 · 146 · 134.58 | Resistance: 156.66 · 159.16 · 163 · 168.34
BNY is at a textbook tactical pullback within a structural uptrend: long-term trend (200 SMA rising at $134.58) is intact ~14.4% above price, medium-term trend (50 SMA at $159.16) just broken to the downside requiring reclaim, and short-term momentum (10 EMA, MACD, RSI) is bearish but possibly bottoming with MACD histogram improving from -1.41 to -1.29. Volatility is contracting (ATR declining from 3.64 to 3.07) supporting a controlled-bounce thesis. Wait-for-confirmation zone: patient dip-buyers should let BNY reclaim the 10 EMA ($156.66) before initiating longs, with stops under the lower band ($152.04). Hard invalidation: weekly close below 200 SMA ($134.58).
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Weekly close below $134 (200 SMA)
Then: Execute structural exit regardless of other conditions
Mean-reversion bounce is setting up at current levels
↩ rebuts: “Bear case to wait for confirmation”
EV: +9.4% to first target at $156.66 (10 EMA), +13.6% to $159.16 (50 SMA), +22.8% to $168.34 (upper Bollinger Band) · concedes: ATR of $3.07 means daily swings of ±1.5% are normal noise; MACD remains negative at -1.29; RSI of 36.51 is not extreme oversold, though improving; Hard invalidation if weekly close below 200 SMA at $134.58
BNY's 34% six-month rally on a broken technical trend and flat sequential earnings is pricing in perfection, leaving investors exposed to multiple compression if Q2 results disappoint or macro sentiment shifts.
EV: -$146 to $148 (~-3% to -5% downside on first target); $134.58 (~-12.5% downside on 200 SMA target) · concedes: Operational track record is impressive: six consecutive quarters of revenue growth, 27% YoY EPS growth, 29.5% net income CAGR; Some premium P/B multiple is justified by return on capital and operating margins; 96% no-cut consensus reduces near-term NIM compression risk; NII trajectory remains positive (though decelerating: +$24M sequential); Buybacks have been a meaningful EPS support (15% share count reduction); 200 SMA still rising — long-term trend not yet broken; Hard invalidation: reclaim of 50 SMA ($159.16) with rising RSI and positive MACD histogram
→ vs conservative: 200 SMA at $134.58 is $19.31 below current price, requiring 12% drawdown to tag; waiting for it to 'catch up' is anchoring, not risk management, and those who waited in 2022 caught a falling knife from $70 to $40
→ vs conservative: Buyback of $4.5 billion in FY25 is accretive over quarters but does not prevent 10% re-rating in a single week; conflating long-term capital return programs with short-term technical floors is a category error
→ vs conservative: Lower Bollinger Band at $152.04 is a statistical level where stops cluster, not a hard bid; it accelerates through once taken out, with next support at $146-148
→ vs neutral: MACD went negative September 15 and hasn't attempted to reclaim signal line; histogram at -1.29 showing 'deceleration' is not reversal; waiting for confirmation means missing the 10% bounce that already gave a better exit
→ vs neutral: 'Wait for confirmation' is paralysis dressed as discipline; three independent momentum gauges aligned bearish and confirmation would only come after a 10% bounce that already provided a better exit
→ vs conservative: Premium multiple of 17.96x P/E and 2.62x P/B prices in continued execution; flat sequential EPS despite 13.9% YoY revenue and 14% ROE makes this a hope trade, not a hold
Market Cap
$104.4B
TTM P/E
17.96
Forward P/E
15.02
PEG Ratio
1.16
Price/Book
2.62
Dividend Yield
1.44%
TTM Revenue
$21.42B
TTM Net Income
$6.024B
Profit Margin
29.4%
Operating Margin
40.0%
ROE
14.1%
ROA
1.26%
TTM EPS
$8.57
Forward EPS
$10.25
2025 Diluted EPS
$7.40
Total Assets
$561.5B
Total Equity
$45.3B
Tangible Book Value
$22.5B
Cash & Equivalents
$187.0B
Long-Term Debt
$32.76B
2025 Operating Cash Flow
$6.73B
2025 Free Cash Flow
$5.18B
2025 Share Buybacks
$4.54B
2025 Dividends Paid
$1.45B
Revenue YoY Growth
+13.9%
EPS YoY Growth
+27%
Net Income CAGR 2022-2025
~29.5%
52-Week High
$165.84
52-Week Low
$103.11
50-Day Average
$159.25
200-Day Average
$135.12
Beta
1.048
Diluted Share Count
692.2M
Strengths
Concerns
HOLD
Macro: Prediction markets price ~96% odds of zero Fed rate cuts in 2026 (+1.9 pp WoW) and only ~6% chance of US recession by year-end 2026 (−3.0 pp WoW), implying rates stay 'higher for longer' and sustaining a maximally supportive backdrop for BNY's NIM, AUM, and cash-management economics. Short-term yields ~3.9% and 10Y near ~5% create a positively sloped curve—historically a bank NIM tailwind. UK and Japan recession odds stand at 4% each, with global recession risk also fading.